Literature DB >> 6102895

Propranolol in the control of blood pressure: a dose-response study.

M J Serlin, M L Orme, N S Baber, R G Sibeon, E Laws, A Breckenridge.   

Abstract

In a double-blind crossover study, it has been shown that the hypotensive response to propranolol in 24 patients with essential hypertension was no greater at doses of 80, 160, or 240 mg twice daily than at 40 mg twice daily. A relationship was observed between dose and response as defined by the ability to achieve a standing diastolic blood pressure of 95 mm Hg. Four patients with low plasma renin activity (PRA) had no fall in blood pressure even at highest dose levels. Plasma propranolol levels in the groups were related to dose, and up to a concentration of 300 ng/ml, with degree of beta-adrenoceptor blockade; there was, however, no correlation with hypotensive response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102895     DOI: 10.1038/clpt.1980.83

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Old antihypertensive agents-diuretics and beta-blockers: do we know how and in whom they lower blood pressure?

Authors:  D A Sica
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 2.  Dose estimation for children.

Authors:  Nigel Baber; Deborah Pritchard
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 3.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 4.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

5.  Antihypertensive effect of propranolol at rest and during exercise.

Authors:  F H Leenen; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

6.  beta-blocker plasma concentrations and inflammatory disease: clinical implications.

Authors:  R E Schneider; H Bishop
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 7.  Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.

Authors:  Ihab Hajjar
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly.

Authors:  A Salvetti; M Lucchini; G Airoldi; M A Cagianelli; G Cinotti; R Cortese; G Diamanti; F Giuntoli; R Pedrinelli; G Pettinà
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.

Authors:  M Schäfer-Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.